Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merrimack Does Well to License Marginal Cancer Drug to Baxter
Merrimack Does Well to License Marginal Cancer Drug to Baxter
Merrimack Does Well to License Marginal Cancer Drug to Baxter
Submitted by
admin
on September 24, 2014 - 8:30am
Source:
TheStreet.com
News Tags:
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Baxter International
Headline:
Merrimack Does Well to License Marginal Cancer Drug to Baxter
Do Not Allow Advertisers to Use My Personal information
